New research suggests that consuming a particular vitamin might not only reduce our risk for disease but actually boost our brain power as well. Egg yolks, fish, and sunlight all have one thing in common—they provide us with vitamin D. This essential vitamin keeps bones, teeth, and muscles healthy; deficiencies increase the risk of an...
Post
Study: Lowering blood pressure helps prevent mental decline
July 25, 2018, by Marilynn Marchione Lowering blood pressure more than usually recommended not only helps prevent heart problems, it also cuts the risk of mental decline that often leads to Alzheimer’s disease, a major study finds. Margaret Graham, 74, has her blood pressure checked while visiting the Wake Forest Baptist Medical Center in Winston-Salem,...
Post
Stem Cell Treatments For Lungs
Lung diseases can be debilitating, making both scientific leader and patients interested in exploring stem cell treatments for lungs an potential treatment approach. Find out all you need to know about stem cell therapy for lungs, including risks, benefits, clinical trial progress and more. A Look At Stem Cell Treatments For Lungs In this article: Progression of...
Post
FDA grants first approval for CA drug under new pilot programs
(HealthDay)—The U.S. Food and Drug Administration has approved Ribociclib (Kisqali) in combination with an aromatase inhibitor (AI) as an initial endocrine-based therapy for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Ribociclib has also been approved with fulvestrant as initial...
Post
4 in 5 adolescent girls have a mental health disorder following sexual assault
July 24, 2018, University College London Eighty percent of young women were found to have a mental health disorder and 55 percent had two or more mental health disorders four to five months after sexual assault, according to a study led by UCL and The Havens, London’s specialist sexual assault referral centres (SARCs) hosted by King’s...
Post
New research focuses on treating non-cognitive symptoms of people with dementia
July 24, 2018, Alzheimer’s Association New research presented at the Alzheimer’s Association International Conference (AAIC) 2018 in Chicago focuses on the recent successes and ongoing challenges of drug and non-drug treatments for the non-cognitive symptoms experienced by people living with Alzheimer’s dementia. Diagram of the brain of a person with Alzheimer’s Disease. Credit: Wikipedia/public domain....
Post
Depleting microbiome with antibiotics can affect glucose metabolism
Salk Institute study in mice finds microbiome-induced changes in the liver may influence diabetes SALK INSTITUTE LA JOLLA–(July 23, 2018) A new study from the Salk Institute has found that mice that have their microbiomes depleted with antibiotics have decreased levels of glucose in their blood and better insulin sensitivity. The research has implications for...
Post
High-throughput flow cytometry in drug discovery
SLAS (SOCIETY FOR LABORATORY AUTOMATION AND SCREENING) A new special issue of SLAS Discovery reflects examples of the recent groundswell of creative new applications for high-throughput flow cytometry (HTFC) in drug discovery. IMAGE: HIGH-THROUGHPUT FLOW CYTOMETRY IN DRUG DISCOVERY. Led by guest editors Mei Ding, Ph.D. (AstraZeneca) and Bruce S. Edwards, Ph.D. (University of New Mexico),...
Post
Common painkillers triple harmful side effects in dementia
Commonly-prescribed opioid-based painkillers led to harmful side effects tripling in people with dementia UNIVERSITY OF EXETER Commonly-prescribed opioid-based painkillers led to harmful side effects tripling in people with dementia. Researchers from the University of Exeter, King’s College London and the University of Bergen are presenting two studies at the Alzheimer’s Association International Conference 2018 (AAIC)...
Post
First practice guidelines for clinical evaluation of Alzheimer’s disease
July 22, 2018, Alzheimer’s Association Despite more than two decades of advances in diagnostic criteria and technology, symptoms of Alzheimer’s disease and Related Dementias (ADRD) too often go unrecognized or are misattributed, causing delays in appropriate diagnoses and care that are both harmful and costly. Contributing to the variability and inefficiency is the lack of...